Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy

Clinical trial NCT02161380 · COMPLETED

Trial details

NCT number: NCT02161380
Sponsor: Byron Lam
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leber's Hereditary Optic Neuropathy

Start date: 2014-07-14
Primary completion: 2023-03-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.